Eleview® can fit easily into your GI practice and this literature offers guidance for optimal use. The following resources have been created to support your practice and staff.

Image of 'Where to use Eleview®' polyp brochure

Identifying optimal polyps brochure

Eleview® is appropriate for a wide range of polyps regardless of their size, location, or type. See how adding Eleview® may benefit your practice.

Download the guide

Cover of guide to clinical best practices for injection of Eleview®

Clinical best practices injection guide

Review the clinical best practices guide to help you optimize the Eleview® lift. Illustrated steps offer guidance on the proper injection technique, helpful hints, and troubleshooting for corrections if problems occur during administration.

Download the guide

Billing and coding for Eleview®

Billing and coding

Created for hospitals and physicians, this guide offers general coding, coverage, and payment information for submitting claims for GI endoscopic procedures with Eleview®. Procedures include polypectomies, EMRs, and ESDs.

Download the guide

Administration procedure steps for Eleview®

Administration and preparation guide

Follow the step-by-step administration procedure with this helpful guide.

Download the guide

Med Staff support for Eleview®

Support for surgical techs and nurses

For surgical technicians, GI nurses, and other medical staff contributing to your practice, this quick sheet highlights preparation, administration, and clinical use of Eleview®.

Download the guide

Eleview® Instructions for Use

Instructions for Use

For additional support and questions, look to the Eleview® Instructions for Use sheet.

Download the guide

How to order Eleview®

For more information and details, visit the Eleview® orders page.

Or contact Aries Customer Service at 888-ARIES-08 or +1-888-274-3708.

Eleview® submucosal injection agent


Eleview® submucosal injectable composition is intended for use in gastrointestinal endoscopic procedures for submucosal lift of polyps, adenomas, early-stage cancers, or other gastrointestinal mucosal lesions, prior to excision with a snare or endoscopic device.


Patients with known sensitivity to any of the components contained in Eleview®.


  • The endoscopist injecting Eleview® must be experienced in the administration technique.
  • The safety of Eleview® has not been established in pregnant or lactating women, or in children under 18 years of age.
  • Eleview® is provided in single-use ampoules. Eleview® should not be reused after the first opening. Any emulsion not injected during the procedure should not be reused for another endoscopic procedure.
  • Do not use if the primary packaging (ampoule) or secondary packaging (aluminum pouch) is damaged.
  • Do not use if the twist-off cap is damaged.
  • Do not use if the emulsion is not clear, shows any signs of opalescence, or contains floating or precipitated visible particles.
  • The product compatibility with other substances has not been tested.


Rarely, local bleeding and/or inflammatory reaction could occur which may or may not be associated with Eleview®.


The administered dose of Eleview® should be determined based on the dimensions of the lesion to be removed. Inject into the submucosa the amount of Eleview® needed to form a submucosal cushion of optimal height and shape for the lesion to be removed. During the procedure do not exceed a total dose of 50 mL per patient, either in single or in multiple administrations.

Please see Instructions for Use for complete Important Safety Information.